49.13% from the same period of the last year. This was mainly because there was a reduction in doubtful account expenses, compared to last year, as well as a reduction in administrative costs. Financing
212.60 183.91 168.81 latoT caooTt d o c oseaot ToToT 1,722.69 1,701.39 1,980.67 Costs of Sale The company has cost of sales of 1,343.99 million baht, 1,437.41 million baht, and 1,450.62 million baht in
1,980.67 2,329.81 2,114.86 Costs of Sale The company has cost of sales of 1,450.62 million baht, 1,650.06 million baht, and 1,636.82 million baht in year 2020, 2021, and 2022 respectively. The cost of sales
to bond issuance?. The paper showed positive response of listed companies? share prices to debenture issuance announcement, supported by the trade-off theory, weighting costs and benefits of debt
find further information in the consolidated financial statements. 2 Analysis of Costs and Expenses 1. In 2019, Cost of sales was 14,187 MTHB, decreased by 1,462 MTHB comparing to 2018 or 9.3% due the
, The Company’s strategies such as increasing more specialty cilinics, medical instruments and expanding into new market so as to drive a sustainable growth Cost of Hospital Operations The costs of
100.0 15,659 100.0 Sales Revenues 20162017 * Note Please find further information in the consolidated financial statements. 2 Analysis of Costs and Expenses 1. In 2017, Cost of sales was 15,317 MTHB
% 128.86 44% (57.48) -45% Other Revenues & Profit Sharing 60.44 43% 31.57 11% 28.87 91% Selling and admin expenses (91.83) -65% (152.14) -52% (60.31) -40% Financial costs (9.22) -7% (12.21) -4% (2.99) -24
expenses 30 28 2 7% 8.0% 7.3% Finance costs 11 13 (2) -18% Share of loss from associate 0 - Income tax expense (1) 1 (3) Profit for the quarter 17 (7) 24 4.6% (1.8%) Consolidated financial information (Unit